Royalty Report: Medical, Coating, Chemicals – Collection: 1670

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 13

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 13

Primary Industries

  • Medical
  • Coating
  • Chemicals
  • Supply
  • Device
  • Therapeutic
  • Delivery
  • Drugs
  • Disease
  • Pharmaceuticals
  • Surgical
  • Stent
  • Agriculture Forestry & Fishing
  • AgroChemical
  • Crop Production
  • Material Composite

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1670

License Grant
Israeli University has assigned to the Company its worldwide rights to patents, patent applications and know-how to develop, manufacture and market products relating to biomedical polymers technology; preventing or reducing post-operative surgical adhesions; dated June 14, 1991, as amended in February 1994, as of January 1996 and as of October 1996; proprietary bioresorbable polymer technology.
License Property
The Company's bioresorbable polymer technology is based on a proprietary group of polymers.  The Company believes that these polymers display desirable properties, which enable them to be tailored to a wide variety of applications.  These properties include bioresorbability, flexibility, strength and biocompatibility.
Field of Use
Potential applications for products derived from these polymers are in medical areas such as the prevention of post-operative adhesions, sutures, stents, implantable device coatings and drug delivery.

IPSCIO Record ID: 5753

License Grant
Licensor hereby grants to Implant a perpetual, worldwide, royalty free license to use any and all technology specifically developed by Licensor for use in the manufacture or coating of the Stents. Licensor hereby agrees to execute and deliver any and all additional documentation Implant reasonably deems necessary or desirable to transfer to Implant the rights set forth in this agreement.
License Property
The parties hereto desire to develop polymer covered or coated vascular stents utilizing proprietary technologies of each party.

The parties agree that upon completion of the research and development contemplated by this Agreement, they will negotiate and enter into an agreement pursuant to which the Licensee will have the exclusive right to manufacture and sell the Stents.

Field of Use
The rights granted relate to vascular stents.

IPSCIO Record ID: 6556

License Grant
Swiss Universities hereby grant Contractor an exclusive, worldwide, perpetual license under their Proprietary Rights in the Technology, without limitation or restriction as to use or field of use.
License Property
The Licensee completed the purchase of the polymer technology assets of a private medical technology company based in the United Kingdom. The assets comprise a series of United States and foreign patent applications as well as scientific and clinical documentation that provide us a second platform technology for future product development. The Licensee also assumed rights and obligations under a development Agreement with the Licensors, as well as with the principal investigator of the technology development project. If the Licensee fails to sublicense the technology or pursue development efforts involving the technology for a period of two years or more, the Licensee is obligated to negotiate a return of the technology to the University.
Field of Use
The Licensee is a biomaterials company engaged in the development and commercialization of innovative and cost-effective medical devices for therapeutic applications.  The products and product candidates, all of which are based on our proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions (scar tissue) following a broad range of surgical procedures.

IPSCIO Record ID: 117

License Grant
Licensor hereby grants Licensee a revertible exclusive license (even to the exclusion of Licensor) to make, have made, use, sell, offer for sale and import Products in the Territory under certain Patent Rights limited to any new patents granted to Licensor for radiopaque polymer coatings and the Know-How required in Licensor's discretion, to practice these certain Patent Rights licensed hereunder. Licensor also grants a non-exclusive license to make, have made, use, sell, offer for sale and import Products in the Territory under certain Patent Rights for patents 4,642,267 and 4,769,013 limited to use on or with radiopaque coatings excluding any use for drug delivery and the Know-How required in Licensor's discretion, to practice these certain Patent Rights licensed hereunder. The rights licensed are collectively referred to as Licensed Patent Rights.
Field of Use
Products means Class 1 intravascular stents for arterial use in humans coated with a radiopaque polymer coating using the Patent Rights and  Class 2 peripheral stents for use in and around the human heart coated with a radiopaque polymer coating using the Patent Rights.

IPSCIO Record ID: 222533

License Grant
Licensor grants to Licensee, a separate worldwide license under Licensor’s Patent Rights and Know-how to make, have made for it only by a properly sublicensed Manufacturer as set forth herein, use, import, and sell that Licensed Product. The license granted herein is expressly limited to the specific Licensed Products defined herein, and does not include the right to sublicense except as set forth.  All licenses granted by Licensor to Licensee under this Agreement are non-exclusive unless specifically stated otherwise for a particular Licensed Product.
License Property
Licensed Products means each of the separately sold Medical Products that bear a Hemocompatable Coating and a Drug Delivery Coating.

Medical Products means the vessel connector and flow-limiter components of a surgically implanted graft prosthetic system for coupling vascular members in the coronary asculature, such as the vessel connector and flow-limiter components of the devices in the illustrations in U.S. Patent 6,241,764 B1.

6,241,764 – Stented grafts for coupling vascular members

Drug-Delivery Coating means chemical compositions comprised of poly(ethylene-co-vinyl acetate) and poly(butyl methacrylate) components for the purpose of releasing Compounds from the chemical composition.

Hemocompatable Coating means chemical coating compositions that contain one or more of the following components photo-reactive polyvinylpyrrolidone copolymer, nonphoto-reactive polyvinylpyrrolidone, photo-reactive heparin, a crosslinking agent known to the parties as PR04, and a compound for promoting polymer-to-metal adhesion and known to the parties as TL03, for the purpose of providing a hemocompatable surface to the Medical Products.

Licensor U.S. Patents

Hemocompatable Coating formulations

1.

METHOD OF IMPROVING THE BIOCOMPATIBILITY OF SOLID SURFACES
U.S. Patent No. 4,973,493 issued 11/27/1990

2.

BIOCOMPATIBLE COATINGS FOR SOLID SURFACES
U.S. Patent No. 4,979,959 issued 12/25/1990

3.

PREPARATION OF POLYMERIC SURFACES VIA COVALENTLY ATTACHING POLYMERS
U.S. Patent No. 5,002,582 issued 3/26/1991

4.

BIOCOMPATIBLE DEVICE WITH COVALENTLY BONDED BIOCOMPATIBLE AGENT
U.S. Patent No. 5,263,992 issued 11/23/1993

5.

SUBSTRATE SURFACE PREPARATION
U.S. Patent No. 5,512,329 issued 4/30/1996

6.

PHOTOACTIVATABLE CROSS-LINKING AGENTS CONTAINING CHARGED GROUPS FOR WATER SOLUBILITY
U.S. Patent No. 6,077,698 issued 06/20/2000

7.

SURFACE COATING AGENTS
U.S. Patent No. 6,278,018 B1 issued 08/21/2001

8.

SURFACE COATING AGENT
U.S. Patent No. 6,603,040B1 issued 8/05/2003

9.

SILANE COATING COMPOSITION
U.S. Patent No. 6,706,408B2 issued 3/16/2004
Drug-Delivery Coating formulations

1.

BIOACTIVE AGENT RELEASE COATING
U.S. Patent No. 6,214,901B1 issued 04/10/2001

2.

BIOACTIVE AGENT RELEASE COATING
U.S. Patent No. 6,344,035B1 issued 02/05/2002

Field of Use
This agreement pertains to coating on medical related devices such as stent.

IPSCIO Record ID: 25882

License Grant
The German Licensee was granted a License by the Licensor to use the patents and technology for coatings comprising hydrophilic polymers used to immobilize molecules and other materials for the purpose of microarraying and to make, use, sell, offer to sell, import and export the Licensed Product on a non-exclusive basis.
License Property
OptiChem(r) surface coatings and assay processing methods. We believe that OptiChem coatings within the sample distribution flow passages will prevent most bacteria from adhering to the passage walls. We believe that applying OptiChem coatings to such devices might significantly reduce bacterial loss during specimen preparation.

Hydrogel Coatings means coatings comprising hydrophilic polymers used to immobilize molecules and other materials for the purpose of microarraying.

United States Patent Application
Title Functional Surface Coating  Publication Number US 2004/0115721 A1  Publication Date June 17, 2004

International Application Published Under the Patent Cooperation Treaty (PCT)
Title Functional Surface Coating  Publication Number WO 03/000433 A1  Publication Date January 3, 2003

United States Provisional Patent Application
Title Composition and Method of Forming a Functional Coating  Date of Deposit April 10, 2004

United States Patent
Title Functional Surface Coating  Publication Number US 6,844,028 B2  Publication Date Jan 18, 2005

United States Patent
Title Functional Surface Coating  Publication Number US 7,067,194 B2  Publication Date Jun 27, 2006

Field of Use
The rights granted apply to surface coatings for the purpose of microarraying preventing bacteria from adhering to passage walls.

IPSCIO Record ID: 1355

License Grant
The Licensee is party to an Agreement relating to the Polymer Technology with the Licensor, an individual.
License Property
The polymer technology is the core technology of a our business.
Field of Use
The biomaterials Licensee is engaged in the development and commercialization of anti-adhesion products. The company is primarily focused on the commercialization of REPEL-CV(TM) Bioresorbable Adhesion Barrier and the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technologies.

IPSCIO Record ID: 209508

License Grant
Licensor, of the Netherlands, grants a non-exclusive, worldwide license to import, export, use, sell, and offer for sale Licensees Stents utilizing, incorporating or coated with Licensors Drug/Polymer Composite Formulation, Biolimus A9 and/or Licensors Polymer Coating in Licensees Licensed Field of Use; and

At Licensees option, a non-exclusive, worldwide license to import, export, use, sell, and offer for sale Licensee Stent Systems incorporating or utilizing Licensors Lubricious Coating.

License Property
The Coated Stents means Licensees Stents marketed, developed or sold by Licensee and coated with Licensors Polymer Coating, Occams Drug/Polymer Composite Formulation, or Biolimus A9.

The Covered Products means either or both Coated Stents and Licensee Stent Systems incorporating or utilizing Licensors Lubricious Coating.

The patents relate to Endovascular Stents and coatings.

Biolimus A9 is formulated to inhibit excessive tissue formation around the stent following implantation, a common side effect called restenosis which often threatens to reverse the clinical benefits of the angioplasty and stent implantation procedures.

Field of Use
Licensees Licensed Field of Use means any applications, procedures, processes or other uses related to drug-eluting, commonly delivered Stents that are delivered as a series of short stents on a delivery catheter wherein the operator has the ability to select the number of short stents as a portion of the total number of stents in the series to be deployed, solely for use in coronary and peripheral vascular applications.

In Japan, Licensees Licensed Field of Use is further limited to treating long lesions, multiple vessels or small vessels in coronary and peripheral applications.

IPSCIO Record ID: 588

License Grant
The Licensor granted to the Licensee a non-exclusive License under the Licensed Patents to the Coating in order for the Licensee to make, have made, import, offer for sale, sell and use Coated Products for medical use in the territory.  The Licensor also granted to the Licensee the right to use the Licensed Marks in connection with Coated Products.
License Property
Licensed Marks means the marks STS and Slip-Coat as used in connection with marketing, promotion, and labeling of Licensed Products and related services, including marks which are registered in any country and marks acquired by usage and common law rights.

Licensed Patents means United States Patent Nos. 5,001,009, 5,069,899, 5,331,027, their foreign counterparts, patent applications on which such patents are based, and any division, continuation, continuation-in-part, reissue or extension thereof.

Field of Use
The rights granted apply for medical use.

IPSCIO Record ID: 2168

License Grant
The Licensor grants to Licensee (ii) an exclusive license, under all proprietary rights existing on the effective date, with right to sublicense, to manufacture or have manufactured, throughout the territory, Superslip Coating, Biostatic Coating and Stay Wet Coating solely for the Licensed Application, (ii) an exclusive license, throughout the Territory, under all Proprietary Rights existing on the Effective Date, with right to sublicense, to apply (or have applied) Superslip Coating, Biostatic Coating and Stay Wet Coating to all products within the Licensed Application, (iii) an exclusive license, throughout the Territory, under all Proprietary Rights existing on the Effective Date, with right to sublicense, to use, sell, offer for sale, import and export all Product.
License Property
Product means any product within the Licensed Application which is coated with Superslip Coating, Biostatic Coating or Stay Wet Coating

Proprietary Rights -means all applications for Letters Patent, issued Letters Patent (including but not limited to United States Letters Patent No. 4,642,267).

Field of Use
Licensed Application means intermittent and indwelling urological catheters.

IPSCIO Record ID: 6778

License Grant
The Company hereby grants to the Licensee an exclusive, worldwide, non-transferable, non-sublicensable, license for all rights to use, make, have made, market, sell, offer for sale, import and export and otherwise exploit the Licensed Technology within the Licensee Fields; provided, however, that the Company shall retain the right to use the Licensed Technology within the Licensee Fields solely as needed to perform its obligations.
License Property
The Company has certain proprietary know-how and technology relating to certain polymer materials. Licensee develops, manufactures and distributes, among other things, gases and specialty chemicals to diversified markets and geographies. The Parties desire to collaborate using the Company's know-how and technology to develop certain personal care, latent catalyst, cleaning and nonwoven products using the Company's know-how and technology and to license certain of that know-how and technology, for Licensee to exploit, as more fully described herein.

Adhesives shall mean a viscoelastic material that remains permanently tacky and will adhere to a wide variety of solid surfaces.

Licensed Trademarks shall mean the mark INTELIMER.

US 6,199,318 Aqueous Emulsions of Crystalline Polymers for Coating Seeds
US 6,540,984 Aqueous Dispersions of Crystalline Polymers and Uses
US 20030147946 Aqueous Dispersions of Crystalline Polymers and Uses

The Company's core polymer products are based on its patented proprietary Intelimer polymers, which differ from other polymers in that they can be customized to abruptly change their physical characteristics when heated or cooled through a pre-set temperature switch. For instance, Intelimer polymers can change within the range of one or two degrees Celsius from a non-adhesive state to a highly tacky, adhesive state; from an impermeable state to a highly permeable state; or from a solid state to a viscous liquid state. These abrupt changes are repeatedly reversible and can be tailored by Licensee to occur at specific temperatures, thereby offering substantial competitive advantages in the Company's target markets.

Intelimer polymers are a proprietary class of synthetic polymeric materials that respond to temperature changes in a controllable, predictable way. Typically, polymers gradually change in adhesion, permeability and viscosity over broad temperature ranges. Licensee's Intelimer materials, in contrast, can be designed to exhibit abrupt changes in permeability, adhesion and/or viscosity over temperature ranges as narrow as 1°C to 2°C. These changes can be designed to occur at relatively low temperatures (0°C to 100°C) that are relatively easy to maintain in industrial and commercial environments. Figure 1 illustrates the effect of temperature on Intelimer materials as compared to typical polymers.

Field of Use
Ag Field shall mean (a) the treatment, coating, sale and/or use of seeds or agricultural products including without limitation corn, soybean, cotton and the like for farming, ornamental and/or other  uses, (b) tubers, seeds and/or plant grafts, (c) all other crops, and (d) all other fruits, vegetables, flowers and the like.

Exclusive Fields shall mean products for (a) personal care, which are not regulated by the FDA, including without limitation i) cosmaceutical products (which may be regulated by the FDA), ii) sunscreen products which are regulated by the FDA and iii) non-pharma transdermal even if applied via an adhesive system ) (collectively the “Personal Care Field”), (b) Thermoset Latent Catalysts, (c) household, industrial and institutional cleaning, excluding floor finishes (e.g. and not by way of limitation, polymers and polymer-based formulations used in the manufacture of hard surface cleaners, equipment cleaning, vehicle cleaning, laundry cleaning, cleaning for food & beverage institutions), and (d) disposable nonwovens (e.g., and not by way of limitation, polymers and polymer-based formulations used in the manufacture of disposables such as paper towels, industrial wipes, surgical gowns, diapers, similar hygiene products, among other disposable nonwoven products).

Food Field shall include, without limitation, the following the packaging, including bulk, pallet and container packaging, of any food related products including without limitation fresh produce, such as fruits and vegetables, flowers, meat, fish and the like.

IPSCIO Record ID: 3747

License Grant
The Licensor desires to grant Licensee, an exclusive perpetual worldwide License to the Licensed Technology, the nordihydroguaratic acid and/or polymer-enhanced collagen processes, compositions and products and/or other biocompatible materials and devices to manufacture, have manufactured, market, use, offer to sell and sell, Licensed Products.
License Property
Licensed Technology means, individually and collectively, all existing patent applications and patents (6,565,960 and 6,821,530) associated with technology related to nordihydroguaratic acid (NDGA) coatings, devices, scaffolds, substrates, or other materials and/or polymer treated collagen material for medical devices, implants, prosthesis and/or constructs and methods for making same.
Field of Use
The Company is a development stage company that acquired a License for the use, adoption and development of certain core technologies developed by the University Research Foundation. This technology focuses on biomaterials for soft tissue repair, such as tendons, ligaments and cartilage, as well as other biomaterial-based products for numerous other medical applications.

IPSCIO Record ID: 27367

License Grant
Licensor of Netherland hereby grants to Licensee of Netherland an exclusive license for the under Patents and Technology to make, have made, use, import, sell, offer to sell or have sold on its behalf product, including the right to sublicense third parties.
License Property
The Company has exclusively licensed its PolyActive polymer biomaterial technology and patents to Matrix; non-allograft bone tissue.

Tissue Adhesion (Barrier); Method for preventing tissue adhesion 08/279,811 5,480,436 525400-99 USA
Tissue Adhesion (Barrier); Method for preventing tissue adhesion 08/078,350 5,508,306 525400-84 USA
Artificial Skin 574654 5,147,401 525400-151 USA
Substrate for treating skin defect (Second PolyActive artificial skin) 08/298,411 Pending 525400-112 USA
Prosthetic Devices formed from materials having bone-bonding properties and uses 08/389,303 Pending 525400-126 USA therefor. Devices of method?
Prosthetic Devices formed from materials having bone-bonding properties and uses 08/089,857 Pending 525400-68 USA therefor. Devices of method?
Polyester ester copolymers as drug delivery matrices 08/699,896 Pending 525400-157 USA

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.